뉴스/Reuters/ProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCPProQR Announces CTA Submission For Phase 1 Study Of AX-0810 Targeting NTCPRefinitiv1분 미만 읽기PRQRProQR Therapeutics NV PRQR:PROQR ANNOUNCES CTA SUBMISSION FOR PHASE 1 STUDY OF AX-0810 TARGETING NTCPReuters네덜란드 주식미국 주식유럽© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html더 보기이 뉴스를 읽으려면 로그인하거나 평생 무료 계정을 만드십시오렛츠고
